The significance of protein N-glycosylation in the pathogenesis of lung cancer and its clinical implications
Cancer Letters · 2025-10 · 631 · 217849
DOI: 10.1016/j.canlet.2025.217849 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Letters, 2025-10. Verfasst von Yibo Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China; Clinical Systems Biology Laboratories, The…. Hauptthemen laut MEDLINE: Lung Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 178 Literaturangaben. Gefördert von: Natural Science Foundation of Henan Province, National Natural Science Foundation of China, Health Commission of Henan Province.
Abstract (Originalsprache)
This comprehensive review systematically elucidates the multifaceted roles of protein N-glycosylation in lung cancer pathogenesis, including its contributions to accelerated cell proliferation, enhanced metastatic potential, promotion of epithelial‒mesenchymal transition (EMT), maintenance of stem cell characteristics, facilitation of immune evasion, preservation of angiogenesis, and diminished drug sensitivity. Additionally, the potential clinical utility of aberrant N-glycosylation is examined as a novel biomarker for early diagnosis, prognostic evaluation, and treatment monitoring in lung cancer. The analysis highlights the critical involvement of N-glycosylation in chemotherapy resistance, targeted therapy, and immunotherapy, offering new perspectives for the development of innovative therapeutic strategies. Furthermore, this review highlights promising applications of antibody-enzyme engineering technology in achieving more precise lung cancer treatments, introducing new opportunities for the field. These findings provide a significant theoretical basis and experimental evidence to support progress in lung cancer research and treatment advancements.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China; Clinical Systems Biology Laboratories, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052,…
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China. Electronic address: songjin0806@163.com.
- Clinical Systems Biology Laboratories, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China; Institute of Infection and Immunity, Henan Academy of Innovations in Medical Science, Zhengz…
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China. Electronic address: lifeng_fah@126.com.
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China. Electronic address: yizhang@zzu.edu.cn.
Förderung
- Natural Science Foundation of Henan Province
- National Natural Science Foundation of China
- Health Commission of Henan Province
- Henan Provincial Science and Technology Research Project
Zitieren
APA
Huang, Y., Song, J., Chen, J., Li, F., Zhang, Y., & Yang, J. H. (2025). The significance of protein N-glycosylation in the pathogenesis of lung cancer and its clinical implications. Cancer Letters, 631, 217849. https://doi.org/10.1016/j.canlet.2025.217849
Vancouver
Huang Y, Song J, Chen J, Li F, Zhang Y, Yang JH. The significance of protein N-glycosylation in the pathogenesis of lung cancer and its clinical implications. Cancer Letters. 2025;631:217849. doi:10.1016/j.canlet.2025.217849
BibTeX
@article{Huang2025,
author = {Huang, Yibo and Song, Jin and Chen, Jinfeng and Li, Feng and Zhang, Yi and Yang, Jing-Hua},
title = {The significance of protein N-glycosylation in the pathogenesis of lung cancer and its clinical implications},
journal = {Cancer Letters},
year = {2025},
volume = {631},
pages = {217849},
doi = {10.1016/j.canlet.2025.217849}
}
EUVIMED